Why Aptevo Therapeutics Stock Is Getting Obliterated
Portfolio Pulse from Henry Khederian
Aptevo Therapeutics Inc (NASDAQ:APVO) has priced its $5 million public offering of 8,064,517 shares at 62 cents per share. The offering, which includes Series A and Series B Warrants for the same number of shares, is expected to close on August 4. The proceeds will be used for working capital purposes.
August 04, 2023 | 11:26 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aptevo Therapeutics' stock price may be negatively impacted in the short term due to the dilution effect of the new share issuance.
The company's decision to issue new shares typically dilutes the value of existing shares, which can lead to a decrease in the stock price. However, the proceeds from the offering will be used for working capital, which could potentially strengthen the company's financial position in the long term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100